Tag: multi-criteria decision analysis

ISPOR 19TH ANNUAL EUROPEAN CONGRESS EXAMINES USE OF MULTI-CRITERIA DECISION ANALYSIS TO SUPPORT HEALTH TECHNOLOGY ASSESSMENT

Vienna, Austria—1 November 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held a workshop this morning entitled, The Potential and Pitfalls of Using Multi-Criteria Decision Analysis to Support Health Technology Assessment. The session took place at the Society’s 19th

Posted in Announcements, ISPOR News & Press Tagged with: , , , ,

ISPOR 21st ANNUAL INTERNATIONAL MEETING CONVENED KEY HEALTH CARE STAKEHOLDERS IN WASHINGTON, DC

Princeton, NJ—June 9, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 21st Annual International Meeting recently concluded in Washington, DC, USA. Government officials, health ministries, and global thought leaders in health economics and outcomes research (HEOR) from more than

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , , , , , , , , ,

ISPOR 21ST ANNUAL INTERNATIONAL MEETING ISSUE PANEL CONSIDERS MCDA AS A POSSIBLE NEW PARADIGM IN HEALTH CARE DECISION MAKING

Washington, DC—May 24, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 21st Annual International Meeting Issue Panel 12—Multi-Criteria Decision Analysis: A New Paradigm in Health Care Decision Making? What Are the Current Status, Challenges, and Opportunities?—was held this afternoon

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , ,

ISPOR PUBLISHES TASK FORCE REPORT #2 ON MULTIPLE CRITERIA DECISION ANALYSIS

Second Report Published in March/April Issue of Value in Health Princeton, NJ—April 5, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) published a new Task Force Report, “Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report

Posted in Announcements, Brief Report, ISPOR News & Press, Value in Health Tagged with: , , , , , , , , , , , ,

ISPOR PUBLISHES NEW TASK FORCE REPORT ON MULTIPLE CRITERIA DECISION ANALYSIS

First of Two Reports Published in Value in Health Princeton, NJ—January 26, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) published a new Task Force Report, “Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , ,

ISPOR’s 3rd PLENARY OF 18th ANNUAL EUROPEAN CONGRESS DISCUSSES MULTI-CRITERIA DECISION ANALYSIS (MCDA)

PANEL REVIEWS RECOMMENDATIONS FROM ISPOR’s MCDA EMERGING GOOD PRACTICE TASK FORCE  Milan, Italy—November 11, 2015—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 18th Annual European Congress third plenary session — Recommendations from the ISPOR Multi-Criteria Decision Analysis Emerging Good

Posted in Announcements, ISPOR News & Press Tagged with: , ,

ISPOR EUROPEAN CONGRESS FOCUSES ON “IMPACTING HEALTH DECISION MAKING WITH OUTCOMES RESEARCH”

18th ANNUAL CONGRESS TO BE HELD 7-11 NOVEMBER, 2015 IN MILAN, ITALY  Princeton, NJ—November 2, 2015—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced confirmation of key scientific sessions for its 18th Annual European Congress starting next week, 7-11

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , , , , , ,

ISPOR 18th ANNUAL EUROPEAN CONGRESS REGISTRATION AT RECORD HIGH

Princeton, NJ—October 13, 2015—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today that its 18th Annual European Congress has registered a record number of delegates for this annual meeting. The Congress will be held 7-11 November 2015 in

Posted in Announcements, ISPOR News & Press Tagged with: , , , ,

Valuing Rare Disease Medicines – We Can Do Better

London, United Kingdom – Many rare diseases, often severe and life-threatening, cannot be treated. The small numbers of patients affected make it time-consuming and costly to compile evidence about treatments. Organisations that pay for health care recognise that a special approach

Posted in Brief Report, Value in Health Tagged with: , , , ,